HUP2000298A1 - Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation - Google Patents

Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation

Info

Publication number
HUP2000298A1
HUP2000298A1 HU2000298A HUP2000298A HUP2000298A1 HU P2000298 A1 HUP2000298 A1 HU P2000298A1 HU 2000298 A HU2000298 A HU 2000298A HU P2000298 A HUP2000298 A HU P2000298A HU P2000298 A1 HUP2000298 A1 HU P2000298A1
Authority
HU
Hungary
Prior art keywords
ibv
coronaviruses
cov
medicinal
formulation
Prior art date
Application number
HU2000298A
Other languages
Hungarian (hu)
Inventor
Laszlo Gyulai
Sardi Eva Dr
Nemeth Zsolt Istvan Dr
Original Assignee
Laszlo Gyulai
Sardi Eva Dr
Nemeth Zsolt Istvan Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laszlo Gyulai, Sardi Eva Dr, Nemeth Zsolt Istvan Dr filed Critical Laszlo Gyulai
Priority to HU2000298A priority Critical patent/HUP2000298A1/en
Priority to PCT/HU2021/000014 priority patent/WO2022112806A2/en
Priority to EP21890365.6A priority patent/EP4210505A2/en
Publication of HUP2000298A1 publication Critical patent/HUP2000298A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HU2000298A 2020-09-11 2020-09-11 Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation HUP2000298A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU2000298A HUP2000298A1 (en) 2020-09-11 2020-09-11 Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation
PCT/HU2021/000014 WO2022112806A2 (en) 2020-09-11 2021-11-10 Food supplement or medicinal or pharmaceutical composition inhibiting virus infection, advantageously infection of sars-cov-2 and ibv coronaviruses and formulation thereof
EP21890365.6A EP4210505A2 (en) 2020-09-11 2021-11-10 Food supplement or medicinal or pharmaceutical composition inhibiting virus infection, advantageously infection of sars-cov-2 and ibv coronaviruses and formulation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2000298A HUP2000298A1 (en) 2020-09-11 2020-09-11 Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation

Publications (1)

Publication Number Publication Date
HUP2000298A1 true HUP2000298A1 (en) 2022-03-28

Family

ID=89993188

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2000298A HUP2000298A1 (en) 2020-09-11 2020-09-11 Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation

Country Status (3)

Country Link
EP (1) EP4210505A2 (en)
HU (1) HUP2000298A1 (en)
WO (1) WO2022112806A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348445C (en) * 1998-10-30 2009-12-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Compositions for the treatment and prevention of cardiovascular diseases
CN100469361C (en) * 2002-06-19 2009-03-18 纽迪希亚公司 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US20200054660A1 (en) * 2016-12-09 2020-02-20 St. Jude Children's Research Hospital Dna methylation profiling for t-cell immunotherapy
WO2021202245A1 (en) * 2020-04-02 2021-10-07 Egaceutical Corporation Viral treatment regimens

Also Published As

Publication number Publication date
WO2022112806A3 (en) 2022-09-01
EP4210505A2 (en) 2023-07-19
WO2022112806A2 (en) 2022-06-02

Similar Documents

Publication Publication Date Title
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
IL217243A (en) Thiophene 2-carboxylic acid derivatives, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments for the treatment of a flaviviridae viral infection or a hepatitis c virus infection
BR112012026596A2 (en) A method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and compositions comprising them.
WO2014003536A8 (en) Dosage regime of fusion compounds
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
WO2007113008A3 (en) Opaque container comprising food or pharmaceutical products or herbal(s)
MX2022010964A (en) Composition comprising an aventhramide or an analogue thereof with improved stability.
MX2021010213A (en) Coronavirus therapeutic agent comprising elaeocarpus sylvestris extract as active ingredient.
EA201101035A1 (en) NEW CONJUGATE OF GRANULOCITAR COLONIUS STIMULATION FACTOR (G-CSF) WITH POLYETHYLENE GLYCOL
MX2022015601A (en) Compound for the treatment of coronaviral infections.
ZA202108771B (en) Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof
ZA202001100B (en) Sterile or sterilized package for administration of medicinal or nutritional substances
HUP2000298A1 (en) Food supplement or medicinal or pharmaceutical composition to control viral infection, particularly sars-cov-2 and ibv coronaviruses and their formulation
WO2016159582A3 (en) Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient
BR112022010574A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING CABOTEGRAVIR
WO2012049430A3 (en) Hydrolysates of animal proteins of marine origin with neuroprotective properties
EP3973976A4 (en) Pharmaceutical composition comprising extract from camellia japonica as active ingredient for prevention and treatment of viral infection
EP4023234A4 (en) Pharmaceutical composition comprising vaccinia virus and hydroxyurea as active ingredient for treatment of cancer
NZ599039A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
BRPI0413714A (en) milk fractions and milk preparations for the treatment and / or prevention of cox-2 mediated diseases
EP4230209A4 (en) Pharmaceutical composition, pharmaceutical combined formulation, and combined formulation kit for prevention or treatment of chronic hepatitis b, each comprising, as active ingredient, oral antiviral agent and therapeutic vaccine including lipopeptide and poly(i:c) adjuvant
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
DE602004025103D1 (en) Medicinal herbal composition for the treatment of AIDS
EP3988539A4 (en) Active ingredient, pharmaceutical composition, and medicinal preparation for therapy of hiv and aids
HUP2000094A1 (en) Medicinal and/or pharmaceutical compositions for intravesical instillation, preparation and use thereof

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished